How AI Is Revolutionizing Biotech & Pharma Research With Liran Belenzon
AI is transforming the way scientists work, making research faster and more efficient. From analyzing massive datasets to accelerating drug discovery, AI is reshaping the lab as we know it.
In this episode, I’m joined by Liran Belenzon, co-founder and CEO of BenchSci, a company revolutionizing how scientists work in the lab. We discuss how AI is transforming pharma research, the challenges of working with scientific data, and how BenchSci is helping top pharmaceutical companies make sense of decades of research.
Liran also shares his journey from an MBA student to leading a company that partners with 12 of the world’s top 20 pharma companies. He also talks about the importance of security and compliance when handling proprietary pharma data and why big pharma companies are choosing to partner with AI-driven platforms rather than building their own solutions.
AI is already changing the landscape of biotech research, but we’re just getting started. Tune in to hear how AI is making labs faster, smarter, and more effective, straight from the frontlines of innovation.
Specifically, this episode highlights the following themes:
- How AI accelerates biotech and pharmaceutical research
- The challenges of cleaning and harmonizing scientific data
- Why big pharma is embracing AI-powered lab solutions
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Liran Belenzon: https://www.linkedin.com/in/liranbelenzon
- Learn more about BenchSci: https://www.benchsci.com
- Follow BenchSci for updates on AI in biotech: https://ca.linkedin.com/company/benchsci
==== Time Stamps ====
00:00 – Introduction
01:18 – About Liran Belenzon
03:42 – The gap in scientific research that led to BenchSci’s creation
07:35 – Challenges in working with unstructured scientific data
10:12 – How AI-powered tools accelerate research and productivity
14:34 – Data security, compliance, and handling proprietary pharma data
17:20 – Why big pharma partners with AI companies instead of building in-house solutions
22:48 – The role of AI in drug discovery and research workflows
25:00 – How multimodal AI enhances lab efficiency
28:15 – The future of AI in biotech and pharma research
30:40 – Liran’s take on leadership, company culture, and innovation
